Search
Legend Biotech Corp
LEGNAdd to Watchlist
23.400USD
+0.860+3.82%
Close 11-06 16:00（ET）
4.55BMarket Cap
LossP/E TTM
After-hours 18:06 (ET)23.520USD+0.085+0.36%
After-hours 18:06 (ET)Legend Biotech Corp (LEGN) Stock Price Target & Forecast
Analyst Rating
Based on 17 analysts giving stock ratings to Legend Biotech Corp in the past month.
Buy
4 Strong Buy
8 Buy
5 Hold
0 Sell
0 Strong Sell
Target Price
48.547USD+124.44%
LEGN Analyst Recommendation Trends
In the current month, LEGN has received 8 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. LEGN average Analyst price target in the last month is 48.547.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
4
4
5
5
5
5
5
5
8
8
8
9
10
11
11
11
5
5
4
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17
17
17
16
17
18
18
18
LEGN Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
argenx SE
ARGX
10
14
3
0
0
27
Beigene Ltd
ONC
8
19
0
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
16
4
0
0
26
Insmed Inc
INSM
6
18
1
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
IQVIA Holdings Inc
IQV
8
13
1
0
0
22
Biontech SE
BNTX
4
12
6
0
0
22
Financial Forecasting
Based on analysts' estimates, LEGN EPS is projected to reach 0.001 in FY2026Q3, following reported EPS of 0.178 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.11
-0.02
0.07
0.00
0.03
Actual
-0.17
-0.29
0.18
--
--
Surprise
-53.63%
-1289.67%
+137.07%
--
--
FAQs
What is Legend Biotech Corp's expected revenue for the next quarter?
Legend Biotech Corp's expected revenue is 361.62M.
What is Legend Biotech Corp's price target?
Analysts forecast that Legend Biotech Corp's price target is USD 48.43, with the highest forecast at USD 69.00 and the lowest forecast at USD 24.00.
What is the analyst rating for Legend Biotech Corp?
Based on the ratings of Legend Biotech Corp's stock from 17 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.